Leptin replacement normalises these hormonal and metabolic alterations, suggesting that leptin deficiency or inactivity is the predominant determinant of obesity associated disorders in these patients (3,9,13). This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.